Humana withdraws 2025 earnings outlook on unsatisfactory MA rates Because of the final rates for next year, Humana will have to enact “larger benefit reductions to achieve stable margins,” its ...

Humana reaffirms the 2025 adjusted EPS outlook of $16.25 versus the consensus of $16.35. For 2025, Humana expects its insurance segment’s benefit ratio guidance of approximately 90.1-90.5%.

It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

Humana delivered 60% adjusted EPS growth in the quarter and maintained its 2025 outlook. On an adjusted operating profit basis, medical insurance grew 75%, including a better medical loss ratio of ...

Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

Humana: The $300 Level Could Get Taken Out In The Near Future; Health insurers slip as U.S. proposes 2025 Medicare Advantage rates; Humana on track for worst monthly drop in a decade on outlook resets ...

Humana Inc. forecast 2025 profit that fell short of Wall Street’s expectations, as the company said it will invest heavily to improve quality in its Medicare Advantage plans that have been hit ...

On Wednesday, Humana Inc (NYSE:HUM), in its first quarter earnings remarks, said the company withdrew its already lowered 2025 profit forecast, citing disappointing government Medicare Advantage ...

Dive Brief: Humana has pulled its profit outlook for 2025, citing declining Medicare Advantage payment rates and other factors creating more uncertainty than normal.. Previously, the insurer ...

Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline. Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, ...